speb/financial-data huggingface dataset:
TMHC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 5866535000.00
TMHC balance_sheet (annual, 2024-12-31) — Tangible Book Value: 5203338000.00
TMHC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TMHC income_statement (annual, 2024-12-31) — Tax Provision: 269548000.00
TMHC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
TMHC balance_sheet (annual, 2024-12-31) — Total Assets: 9297131000.00
TMHC balance_sheet (annual, 2024-12-31) — Total Capitalization: 7987018000.00
TMHC balance_sheet (annual, 2024-12-31) — Total Debt: 2199481000.00
TMHC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5878180000.00
TMHC income_statement (annual, 2024-12-31) — Total Expenses: 6954422000.00
TMHC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3418951000.00
TMHC balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1779600000.00
TMHC balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2663655000.00
TMHC income_statement (annual, 2024-12-31) — Total Other Finance Cost: 13316000.00
TMHC income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 5893000.00
TMHC balance_sheet (annual, 2024-12-31) — Total Tax Payable: 38818000.00
TMHC income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
TMHC income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
TMHC income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TMHC income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TMHC balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 59819731.00
TMHC balance_sheet (annual, 2024-12-31) — Treasury Stock: 1616170000.00
TMHC balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 1616170000.00
TMHC balance_sheet (annual, 2024-12-31) — Working Capital: 6762235000.00
TMHC income_statement (quarterly, 2025-03-31) — +Operating Expense: 176624000.00
TMHC income_statement (quarterly, 2025-03-31) — +Total Revenue: 1896019000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 276526000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3088464000.00
TMHC cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 14878000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 225100000.00
TMHC income_statement (quarterly, 2025-03-31) — Basic Average Shares: 101245000.00
TMHC income_statement (quarterly, 2025-03-31) — Basic EPS: 2.11
TMHC cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 487166000.00
TMHC cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -8513000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 75047000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 377815000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 377815000.00
TMHC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -141189000.00
TMHC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -45105000.00
TMHC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 77231000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -117349000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 64814000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Inventory: -79943000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 3567000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Payable: -52535000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -52535000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Receivables: -46004000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 64814000.00
TMHC cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -174915000.00
TMHC cash_flow (quarterly, 2025-03-31) — Changes In Cash: -109063000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5946007000.00
TMHC cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -135093000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 302583000.00
TMHC income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1432745000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 219929000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Current Assets: 7166833000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 242718000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 242718000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 840560000.00
TMHC cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 9021000.00
TMHC cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 9021000.00
TMHC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 103017000.00
TMHC income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.07
TMHC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 213466000.00
TMHC cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 3096000.00
TMHC cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 0.00
TMHC income_statement (quarterly, 2025-03-31) — EBIT: 287068000.00
TMHC income_statement (quarterly, 2025-03-31) — EBITDA: 296089000.00
TMHC income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 1975000.00
TMHC cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -1975000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 84155000.00
TMHC cash_flow (quarterly, 2025-03-31) — End Cash Position: 378103000.00
TMHC cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -141189000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Finished Goods: 6351434000.00
TMHC cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 68718000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2509000.00
TMHC income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 67548000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Goodwill: 663197000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Gross PPE: 614871000.00
TMHC income_statement (quarterly, 2025-03-31) — Gross Profit: 463274000.00
TMHC cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 24000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 67057000.00
TMHC income_statement (quarterly, 2025-03-31) — Interest Expense: 8499000.00
TMHC income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 8499000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Interest Payable: 29328000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Inventory: 6351434000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8029606000.00
TMHC cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -45105000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 475192000.00
TMHC cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 854722000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 0.00
TMHC balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 75047000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2083599000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2158646000.00
TMHC cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 854722000.00
TMHC cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -854762000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 475192000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 212483000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Minority Interest: 11517000.00
TMHC income_statement (quarterly, 2025-03-31) — Minority Interests: -265000.00
TMHC cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -36592000.00
TMHC cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -135093000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Net Debt: 1705784000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Income: 213466000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 213466000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 213731000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 213466000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 213466000.00
TMHC cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 213731000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 213731000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Interest Income: -8499000.00
TMHC cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
TMHC cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -40000.00
TMHC cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -40000.00
TMHC income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -8499000.00
TMHC cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -393000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Net PPE: 614871000.00
TMHC cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -8513000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5282810000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 76248000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 76248000.00
TMHC income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 296089000.00
TMHC income_statement (quarterly, 2025-03-31) — Normalized Income: 213466000.00
TMHC cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 77231000.00
TMHC cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1975000.00
TMHC income_statement (quarterly, 2025-03-31) — Operating Income: 286650000.00
TMHC income_statement (quarterly, 2025-03-31) — Operating Revenue: 1896019000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 100532019.00
TMHC balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2509000.00
TMHC income_statement (quarterly, 2025-03-31) — Other Gand A: 67548000.00
TMHC income_statement (quarterly, 2025-03-31) — Other Income Expense: 418000.00
TMHC cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 5610000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 387787000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 130760000.00
TMHC income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1557000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Other Properties: 312288000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Other Receivables: 212196000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Payables: 377913000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 597842000.00
TMHC income_statement (quarterly, 2025-03-31) — Pretax Income: 278569000.00
TMHC cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -5663000.00
TMHC cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -36592000.00
TMHC cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
TMHC cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -8513000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Receivables: 212196000.00
TMHC income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1432745000.00
TMHC income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 9021000.00
TMHC cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -854762000.00
TMHC cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -135093000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 288000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4607319000.00
TMHC cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
TMHC income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 109076000.00
TMHC income_statement (quarterly, 2025-03-31) — Selling General And Administration: 176624000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Share Issued: 162595745.00
TMHC cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7785000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5946007000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5282810000.00
TMHC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TMHC income_statement (quarterly, 2025-03-31) — Tax Provision: 64838000.00
TMHC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
TMHC balance_sheet (quarterly, 2025-03-31) — Total Assets: 9384128000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8029606000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Total Debt: 2158646000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5957524000.00
TMHC income_statement (quarterly, 2025-03-31) — Total Expenses: 1609369000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3426604000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2217295000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2586044000.00
TMHC income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 8499000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 101387000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 62063726.00
TMHC balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 1752286000.00
TMHC balance_sheet (quarterly, 2025-03-31) — Working Capital: 6326273000.00
TMHC income_statement (quarterly, 2025-06-30) — +Operating Expense: 183044000.00
TMHC income_statement (quarterly, 2025-06-30) — +Total Revenue: 2030070000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 311578000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3097120000.00
TMHC cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 6754000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 220210000.00
TMHC income_statement (quarterly, 2025-06-30) — Basic Average Shares: 99537000.00
TMHC income_statement (quarterly, 2025-06-30) — Basic EPS: 1.94
TMHC cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 378103000.00
TMHC cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7680000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 74408000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 130174000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 130174000.00
TMHC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -106869000.00
TMHC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -11013000.00
TMHC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -125957000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 99432000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -67057000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Inventory: -243194000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -31232000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Payable: 32375000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 32375000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Receivables: -114033000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -67057000.00
TMHC cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -356084000.00
TMHC cash_flow (quarterly, 2025-06-30) — Changes In Cash: -243839000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6047260000.00
TMHC cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -100000000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 352395000.00
TMHC income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1562582000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 244549000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Current Assets: 7551305000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 211486000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 211486000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 800953000.00
TMHC cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 10146000.00
TMHC cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 10146000.00
TMHC income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 100923000.00
TMHC income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.92
TMHC income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 193577000.00
TMHC cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 4167000.00
TMHC cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 8612000.00
TMHC income_statement (quarterly, 2025-06-30) — EBIT: 284444000.00
TMHC income_statement (quarterly, 2025-06-30) — EBITDA: 294590000.00
TMHC income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 326000.00
TMHC cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -326000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 81829000.00
TMHC cash_flow (quarterly, 2025-06-30) — End Cash Position: 134264000.00
TMHC cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -106869000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Finished Goods: 6505862000.00
TMHC cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -133637000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2509000.00
TMHC income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 66655000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Goodwill: 663197000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Gross PPE: 685210000.00
TMHC income_statement (quarterly, 2025-06-30) — Gross Profit: 467488000.00
TMHC cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 156705000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
TMHC balance_sheet (quarterly, 2025-06-30) — Interest Payable: 36021000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Inventory: 6505862000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8146637000.00
TMHC cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -11013000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 474684000.00
TMHC cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 970111000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
TMHC balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 74408000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2099377000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2173785000.00
TMHC cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 970111000.00
TMHC cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -974555000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 474684000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 237655000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Minority Interest: 10602000.00
TMHC income_statement (quarterly, 2025-06-30) — Minority Interests: -2408000.00
TMHC cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -11945000.00
TMHC cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -100000000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Net Debt: 1969203000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Income: 193577000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 193577000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 195985000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 193577000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 193577000.00
TMHC cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 195985000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 195985000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Interest Income: -13819000.00
TMHC cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -4444000.00
TMHC cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -4444000.00
TMHC income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -13819000.00
TMHC cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -3065000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Net PPE: 685210000.00
TMHC cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -7680000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 5384063000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 76248000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 76248000.00
TMHC income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 294590000.00
TMHC income_statement (quarterly, 2025-06-30) — Normalized Income: 193577000.00
TMHC cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -125957000.00
TMHC cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -326000.00
TMHC income_statement (quarterly, 2025-06-30) — Operating Income: 284444000.00
TMHC income_statement (quarterly, 2025-06-30) — Operating Revenue: 2030070000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 98835264.00
TMHC balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 449971000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2509000.00
TMHC income_statement (quarterly, 2025-06-30) — Other Gand A: 66655000.00
TMHC income_statement (quarterly, 2025-06-30) — Other Income Expense: -7362000.00
TMHC cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 5385000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 98560000.00
TMHC income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -7688000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Other Properties: 332815000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Other Receivables: 240998000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Payables: 344918000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 589467000.00
TMHC income_statement (quarterly, 2025-06-30) — Pretax Income: 263263000.00
TMHC cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 640000.00
TMHC cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -11945000.00
TMHC cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -7680000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Receivables: 240998000.00
TMHC income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1562582000.00
TMHC income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 10146000.00
TMHC cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -974555000.00
TMHC cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -100000000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 4090000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 4800896000.00
TMHC income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 116389000.00
TMHC income_statement (quarterly, 2025-06-30) — Selling General And Administration: 183044000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Share Issued: 162628426.00
TMHC cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 8016000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6047260000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 5384063000.00
TMHC income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TMHC income_statement (quarterly, 2025-06-30) — Tax Provision: 67278000.00
TMHC income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
TMHC balance_sheet (quarterly, 2025-06-30) — Total Assets: 9450644000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 8146637000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Total Debt: 2173785000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6057862000.00
TMHC income_statement (quarterly, 2025-06-30) — Total Expenses: 1745626000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3392782000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1899339000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2591829000.00
TMHC income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 13819000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 33340000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 63793162.00
TMHC balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1853266000.00
TMHC balance_sheet (quarterly, 2025-06-30) — Working Capital: 6750352000.00
TMHC income_statement (quarterly, 2025-09-30) — +Operating Expense: 180701000.00
TMHC income_statement (quarterly, 2025-09-30) — +Total Revenue: 2095751000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 285207000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 3107743000.00
TMHC cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 7189000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 198548000.00
TMHC income_statement (quarterly, 2025-09-30) — Basic Average Shares: 98439000.00
TMHC income_statement (quarterly, 2025-09-30) — Basic EPS: 2.05
TMHC cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 134264000.00
TMHC cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -13047000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 73048000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 370591000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 370591000.00
TMHC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 44801000.00
TMHC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -27788000.00
TMHC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 219640000.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -34050000.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 0.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Inventory: 87351000.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -48053000.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Payable: -34050000.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -34050000.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Receivables: -42650000.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 0.00
TMHC cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -37402000.00
TMHC cash_flow (quarterly, 2025-09-30) — Changes In Cash: 236653000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6184129000.00
TMHC cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -74553000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 360633000.00
TMHC income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1619130000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 245231000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Current Assets: 7693536000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 163433000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 163433000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 738240000.00
TMHC cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 10405000.00
TMHC cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 10405000.00
TMHC income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 100048000.00
TMHC income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.01
TMHC income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 201441000.00
TMHC cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 2821000.00
TMHC cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 10168000.00
TMHC income_statement (quarterly, 2025-09-30) — EBIT: 295920000.00
TMHC income_statement (quarterly, 2025-09-30) — EBITDA: 306325000.00
TMHC income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 1253000.00
TMHC cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -1253000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 108142000.00
TMHC cash_flow (quarterly, 2025-09-30) — End Cash Position: 370917000.00
TMHC cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 44801000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Finished Goods: 6403084000.00
TMHC cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 206593000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2509000.00
TMHC income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 65275000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Goodwill: 663197000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Gross PPE: 706722000.00
TMHC income_statement (quarterly, 2025-09-30) — Gross Profit: 476621000.00
TMHC cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 73478000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 0.00
TMHC balance_sheet (quarterly, 2025-09-30) — Interest Payable: 30589000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Inventory: 6403084000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8374890000.00
TMHC cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -27788000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 487857000.00
TMHC cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1160599000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
TMHC balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 73048000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2190761000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2263809000.00
TMHC cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 1160599000.00
TMHC cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1042541000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 487857000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 221294000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Minority Interest: 13386000.00
TMHC income_statement (quarterly, 2025-09-30) — Minority Interests: -3010000.00
TMHC cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -24909000.00
TMHC cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -74553000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Net Debt: 1820170000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Income: 201441000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 201441000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 204451000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 201441000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 201441000.00
TMHC cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 204451000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 204451000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Interest Income: -12774000.00
TMHC cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 118058000.00
TMHC cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 118058000.00
TMHC income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -12774000.00
TMHC cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2791000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Net PPE: 706722000.00
TMHC cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -13047000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5520932000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 76248000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 76248000.00
TMHC income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 306325000.00
TMHC income_statement (quarterly, 2025-09-30) — Normalized Income: 201441000.00
TMHC cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 219640000.00
TMHC cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1253000.00
TMHC income_statement (quarterly, 2025-09-30) — Operating Income: 295920000.00
TMHC income_statement (quarterly, 2025-09-30) — Operating Revenue: 2095751000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 97710938.00
TMHC balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 455017000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 2509000.00
TMHC income_statement (quarterly, 2025-09-30) — Other Gand A: 65275000.00
TMHC income_statement (quarterly, 2025-09-30) — Other Income Expense: -10751000.00
TMHC cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 26893000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 98560000.00
TMHC income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -12004000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Other Properties: 346089000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Other Receivables: 265970000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Payables: 329576000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 574807000.00
TMHC income_statement (quarterly, 2025-09-30) — Pretax Income: 272395000.00
TMHC cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 4087000.00
TMHC cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -24909000.00
TMHC cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -13047000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Receivables: 265970000.00
TMHC income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1619130000.00
TMHC income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 10405000.00
TMHC cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1042541000.00
TMHC cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -74553000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 326000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 5002337000.00
TMHC income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 115426000.00
TMHC income_statement (quarterly, 2025-09-30) — Selling General And Administration: 180701000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Share Issued: 162781633.00
TMHC cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6536000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6184129000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 5520932000.00
TMHC income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TMHC income_statement (quarterly, 2025-09-30) — Tax Provision: 67944000.00
TMHC income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
TMHC balance_sheet (quarterly, 2025-09-30) — Total Assets: 9627560000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8374890000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Total Debt: 2263809000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6197515000.00
TMHC income_statement (quarterly, 2025-09-30) — Total Expenses: 1799831000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3430045000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1934024000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2691805000.00
TMHC income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 12774000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 44369000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 65070695.00
TMHC balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 1928461000.00
TMHC balance_sheet (quarterly, 2025-09-30) — Working Capital: 6955296000.00
TMHC income_statement (annual, 2025-12-31) — +Operating Expense: 734991000.00
TMHC income_statement (quarterly, 2025-12-31) — +Operating Expense: 194622000.00
TMHC income_statement (annual, 2025-12-31) — +Total Revenue: 8121480000.00
TMHC income_statement (quarterly, 2025-12-31) — +Total Revenue: 2099640000.00
TMHC balance_sheet (annual, 2025-12-31) — Accounts Payable: 251641000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 251641000.00
TMHC balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 3114898000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 3114898000.00
TMHC cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 28821000.00
TMHC cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
TMHC balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 132512000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 132512000.00
TMHC income_statement (annual, 2025-12-31) — Basic Average Shares: 99069000.00
TMHC income_statement (quarterly, 2025-12-31) — Basic Average Shares: 97106000.00
TMHC income_statement (annual, 2025-12-31) — Basic EPS: 7.90
TMHC income_statement (quarterly, 2025-12-31) — Basic EPS: 1.79
TMHC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 487166000.00
TMHC cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 370917000.00
TMHC cash_flow (annual, 2025-12-31) — Capital Expenditure: -40372000.00
TMHC cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -11132000.00
TMHC balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 71525000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 71525000.00
TMHC balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
TMHC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 850037000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 850037000.00
TMHC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 850037000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 850037000.00
TMHC cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -298508000.00
TMHC cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -95251000.00
TMHC cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -154772000.00
TMHC cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -70866000.00
TMHC cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 817345000.00
TMHC cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 646431000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Account Payable: 81990000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 133957000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 5903000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 8146000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Inventory: 26578000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Inventory: 262364000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -114122000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -38404000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Payable: 87893000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Payable: 142103000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 87893000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 142103000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Receivables: -183070000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Receivables: 19617000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Tax Payable: 5903000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 8146000.00
TMHC cash_flow (annual, 2025-12-31) — Change In Working Capital: -182721000.00
TMHC cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 385680000.00
TMHC cash_flow (annual, 2025-12-31) — Changes In Cash: 364065000.00
TMHC cash_flow (quarterly, 2025-12-31) — Changes In Cash: 480314000.00
TMHC balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
TMHC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6293322000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6293322000.00
TMHC cash_flow (annual, 2025-12-31) — Common Stock Payments: -381016000.00
TMHC cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -71370000.00
TMHC balance_sheet (annual, 2025-12-31) — Construction In Progress: 360690000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 360690000.00
TMHC income_statement (annual, 2025-12-31) — Cost Of Revenue: 6251272000.00
TMHC income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1636815000.00
TMHC balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 298234000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 298234000.00
TMHC balance_sheet (annual, 2025-12-31) — Current Assets: 7932754000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Current Assets: 7932754000.00
TMHC balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 125029000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 125029000.00
TMHC balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 125029000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 125029000.00
TMHC balance_sheet (annual, 2025-12-31) — Current Liabilities: 713797000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 713797000.00
TMHC cash_flow (annual, 2025-12-31) — Deferred Income Tax: 1885000.00
TMHC cash_flow (annual, 2025-12-31) — Deferred Tax: 1885000.00
TMHC cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 40182000.00
TMHC cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 10610000.00
TMHC cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 40182000.00
TMHC cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 10610000.00
TMHC income_statement (annual, 2025-12-31) — Diluted Average Shares: 100707000.00
TMHC income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 98656000.00
TMHC income_statement (annual, 2025-12-31) — Diluted EPS: 7.77
TMHC income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.76
TMHC income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 782500000.00
TMHC income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 174016000.00
TMHC cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 12789000.00
TMHC cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 2705000.00
TMHC cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 30401000.00
TMHC cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 11621000.00
TMHC income_statement (annual, 2025-12-31) — EBIT: 1135217000.00
TMHC income_statement (quarterly, 2025-12-31) — EBIT: 268203000.00
TMHC income_statement (annual, 2025-12-31) — EBITDA: 1175399000.00
TMHC income_statement (quarterly, 2025-12-31) — EBITDA: 278813000.00
TMHC income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 4867000.00
TMHC income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 1313000.00
TMHC cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -4867000.00
TMHC cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -1313000.00
TMHC balance_sheet (annual, 2025-12-31) — Employee Benefits: 125878000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 125878000.00
TMHC cash_flow (annual, 2025-12-31) — End Cash Position: 851231000.00
TMHC cash_flow (quarterly, 2025-12-31) — End Cash Position: 851231000.00
TMHC cash_flow (annual, 2025-12-31) — Financing Cash Flow: -298508000.00
TMHC cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -95251000.00
TMHC balance_sheet (annual, 2025-12-31) — Finished Goods: 6140663000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Finished Goods: 6140663000.00
TMHC cash_flow (annual, 2025-12-31) — Free Cash Flow: 776973000.00
TMHC cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 635299000.00
TMHC balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2597000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2597000.00
TMHC income_statement (annual, 2025-12-31) — General And Administrative Expense: 273506000.00
TMHC income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 74028000.00
TMHC balance_sheet (annual, 2025-12-31) — Goodwill: 663197000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Goodwill: 663197000.00
TMHC balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 663197000.00
TMHC balance_sheet (annual, 2025-12-31) — Gross PPE: 680505000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Gross PPE: 680505000.00
TMHC income_statement (annual, 2025-12-31) — Gross Profit: 1870208000.00
TMHC income_statement (quarterly, 2025-12-31) — Gross Profit: 462825000.00
TMHC cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 303965000.00
TMHC cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 73758000.00
TMHC balance_sheet (annual, 2025-12-31) — Income Tax Payable: 8146000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 8146000.00
TMHC balance_sheet (annual, 2025-12-31) — Interest Payable: 39701000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Interest Payable: 39701000.00
TMHC balance_sheet (annual, 2025-12-31) — Inventory: 6140663000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Inventory: 6140663000.00
TMHC balance_sheet (annual, 2025-12-31) — Invested Capital: 8584429000.00
TMHC balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8584429000.00